[1]
|
Bioengineering of Antibody Fragments: Challenges and Opportunities
Bioengineering,
2023
DOI:10.3390/bioengineering10020122
|
|
|
[2]
|
Antibody‐Incorporated Nanomedicines for Cancer Therapy
Advanced Materials,
2022
DOI:10.1002/adma.202109210
|
|
|
[3]
|
Current approaches of nanomedicines in the market and various stage of clinical translation
Acta Pharmaceutica Sinica B,
2022
DOI:10.1016/j.apsb.2022.02.025
|
|
|
[4]
|
A Non-radiometric Approach to Determine Tissue Vascular Blood Volume in Biodistribution Studies
The AAPS Journal,
2022
DOI:10.1208/s12248-022-00770-6
|
|
|
[5]
|
Cloning and expression of antibody fragment (Fab) I: Effect of expression construct and induction strategies on light and heavy chain gene expression
Biochemical Engineering Journal,
2021
DOI:10.1016/j.bej.2021.108189
|
|
|
[6]
|
Cloning and expression of antibody fragment (Fab) I: Effect of expression construct and induction strategies on light and heavy chain gene expression
Biochemical Engineering Journal,
2021
DOI:10.1016/j.bej.2021.108189
|
|
|
[7]
|
Methods to generate site-specific conjugates of antibody and protein
Bioorganic & Medicinal Chemistry,
2021
DOI:10.1016/j.bmc.2020.115946
|
|
|
[8]
|
Human Single-Chain Antibodies That Neutralize Elastolytic Activity of Pseudomonas aeruginosa LasB
Pathogens,
2021
DOI:10.3390/pathogens10060765
|
|
|
[9]
|
Zielgerichtete Wirkstoffe für die Krebstherapie: Aktuelle Entwicklungen und Perspektiven
Angewandte Chemie,
2021
DOI:10.1002/ange.201914511
|
|
|
[10]
|
Targeted Engineering of Medicinal Chemistry for Cancer Therapy: Recent Advances and Perspectives
Angewandte Chemie International Edition,
2021
DOI:10.1002/anie.201914511
|
|
|
[11]
|
Antibody-Drug Conjugates
Methods in Molecular Biology,
2020
DOI:10.1007/978-1-4939-9929-3_1
|
|
|
[12]
|
Zielgerichtete Wirkstoffe für die Krebstherapie: Aktuelle Entwicklungen und Perspektiven
Angewandte Chemie,
2020
DOI:10.1002/ange.201914511
|
|
|
[13]
|
Targeted Engineering of Medicinal Chemistry for Cancer Therapy: Recent Advances and Perspectives
Angewandte Chemie International Edition,
2020
DOI:10.1002/anie.201914511
|
|
|
[14]
|
Homogenous Scavenging Resolves Low-Purification Yield/Selectivity Caused by Secondary Binding of Protein-A to Antigen-Binding Antibody Fragments
Biomacromolecules,
2020
DOI:10.1021/acs.biomac.9b01516
|
|
|
[15]
|
Challenges and strategies for next-generation bispecific antibody-based antitumor therapeutics
Cellular & Molecular Immunology,
2020
DOI:10.1038/s41423-020-0417-8
|
|
|
[16]
|
Homogenous Scavenging Resolves Low-Purification Yield/Selectivity Caused by Secondary Binding of Protein-A to Antigen-Binding Antibody Fragments
Biomacromolecules,
2020
DOI:10.1021/acs.biomac.9b01516
|
|
|
[17]
|
Challenges and strategies for next-generation bispecific antibody-based antitumor therapeutics
Cellular & Molecular Immunology,
2020
DOI:10.1038/s41423-020-0417-8
|
|
|
[18]
|
Combining the best of two worlds: Highly flexible chimeric antigen receptor adaptor molecules (CAR-adaptors) for the recruitment of chimeric antigen receptor T cells
mAbs,
2019
DOI:10.1080/19420862.2019.1596511
|
|
|
[19]
|
Considerations for the Design of Antibody-Based Therapeutics
Journal of Pharmaceutical Sciences,
2019
DOI:10.1016/j.xphs.2019.05.031
|
|
|
[20]
|
Antibody Fragments as Potential Biopharmaceuticals for Cancer Therapy: Success and Limitations
Current Medicinal Chemistry,
2019
DOI:10.2174/0929867324666170817152554
|
|
|
[21]
|
Tuning the Hydrolytic Stability of Next Generation Maleimide Cross-Linkers Enables Access to Albumin-Antibody Fragment Conjugates and tri-scFvs
Bioconjugate Chemistry,
2018
DOI:10.1021/acs.bioconjchem.7b00795
|
|
|
[22]
|
Docetaxel loaded immunonanoparticles delivery in EGFR overexpressed breast carcinoma cells
Journal of Drug Delivery Science and Technology,
2018
DOI:10.1016/j.jddst.2018.03.027
|
|
|
[23]
|
Enhanced expression of soluble antibody fragments by low-temperature and overdosing with a nitrogen source
Enzyme and Microbial Technology,
2018
DOI:10.1016/j.enzmictec.2018.04.002
|
|
|
[24]
|
Advances in Biochemical Engineering/Biotechnology,
2018
DOI:10.1007/10_2016_57
|
|
|
[25]
|
Overview of Antibody Drug Delivery
Pharmaceutics,
2018
DOI:10.3390/pharmaceutics10030083
|
|
|
[26]
|
New Bioprocessing Strategies: Development and Manufacturing of Recombinant Antibodies and Proteins
Advances in Biochemical Engineering/Biotechnology,
2018
DOI:10.1007/10_2016_57
|
|
|
[27]
|
Tuning the Hydrolytic Stability of Next Generation Maleimide Cross-Linkers Enables Access to Albumin-Antibody Fragment Conjugates and tri-scFvs
Bioconjugate Chemistry,
2018
DOI:10.1021/acs.bioconjchem.7b00795
|
|
|
[28]
|
Microbial platform technology for recombinant antibody fragment production: A review
Critical Reviews in Microbiology,
2017
DOI:10.3109/1040841X.2016.1150959
|
|
|
[29]
|
Fc Engineering for Developing Therapeutic Bispecific Antibodies and Novel Scaffolds
Frontiers in Immunology,
2017
DOI:10.3389/fimmu.2017.00038
|
|
|
[30]
|
Development of a novel nano-sized anti-VEGFA nanobody with enhanced physicochemical and pharmacokinetic properties
Artificial Cells, Nanomedicine, and Biotechnology,
2017
DOI:10.1080/21691401.2017.1369426
|
|
|
[31]
|
Ligand-Targeted Drug Delivery
Chemical Reviews,
2017
DOI:10.1021/acs.chemrev.7b00013
|
|
|
[32]
|
Cryogel-supported stem cell factory for customized sustained release of bispecific antibodies for cancer immunotherapy
Scientific Reports,
2017
DOI:10.1038/srep42855
|
|
|
[33]
|
Cryogel-supported stem cell factory for customized sustained release of bispecific antibodies for cancer immunotherapy
Scientific Reports,
2017
DOI:10.1038/srep42855
|
|
|
[34]
|
Ligand-Targeted Drug Delivery
Chemical Reviews,
2017
DOI:10.1021/acs.chemrev.7b00013
|
|
|
[35]
|
Approach for Half-Life Extension of Small Antibody Fragments That Does Not Affect Tissue Uptake
Bioconjugate Chemistry,
2016
DOI:10.1021/acs.bioconjchem.6b00469
|
|
|
[36]
|
Approach for Half-Life Extension of Small Antibody Fragments That Does Not Affect Tissue Uptake
Bioconjugate Chemistry,
2016
DOI:10.1021/acs.bioconjchem.6b00469
|
|
|
[37]
|
Co-stimulation Blockade Plus T-Cell Depletion in Transplant Patients: Towards a Steroid- and Calcineurin Inhibitor-Free Future?
Drugs,
2016
DOI:10.1007/s40265-016-0656-2
|
|
|
[38]
|
Biosimilars of Monoclonal Antibodies
2016
DOI:10.1002/9781118940648.ch21
|
|
|
[39]
|
Evaluation of pharmacokinetics and pharmacodynamics and clinical efficacy of certolizumab pegol for Crohn’s disease
Expert Opinion on Drug Metabolism & Toxicology,
2015
DOI:10.1517/17425255.2015.995166
|
|
|
[40]
|
Encapsidated Atom-Transfer Radical Polymerization in Qβ Virus-like Nanoparticles
ACS Nano,
2014
DOI:10.1021/nn502043d
|
|
|
[41]
|
Encapsidated Atom-Transfer Radical Polymerization in Qβ Virus-like Nanoparticles
ACS Nano,
2014
DOI:10.1021/nn502043d
|
|
|